Referências
Principais artigos
Centers for Disease Control and Prevention. Sexually transmitted infections treatment guidelines, 2021. Jul 2021 [internet publication].Texto completo
Sherrard J, Wilson J, Donders G, et al. 2018 European (IUSTI/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge. Int J STD AIDS. 2018 Nov;29(13):1258-72. Resumo
Miller JM, Binnicker MJ, Campbell S, et al. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis. 2018 Aug 31;67(6):e1-94.Texto completo Resumo
Artigos de referência
1. Watson LJ, James KE, Hatoum Moeller IJ, et al. Vulvovaginal discomfort is common in both premenopausal and postmenopausal women. J Low Genit Tract Dis. 2019 Apr;23(2):164-9. Resumo
2. Foxman B, Marsh JV, Gillespie B, et al. Frequency and response to vaginal symptoms among white and African American women: Results of a random digit dialing survey. J Womens Health. 1998 Nov;7(9):1167-74. Resumo
3. Patel V, Pednekar S, Weiss H, et al. Why do women complain of vaginal discharge? A population survey of infectious and pyschosocial risk factors in a South Asian community. Int J Epidemiol. 2005 Aug;34(4):853-62.Texto completo Resumo
4. Hillier SL, Austin M, Macio I, et al. Diagnosis and treatment of vaginal discharge syndromes in community practice settings. Clin Infect Dis. 2021 May 4;72(9):1538-43.Texto completo Resumo
5. National Institute for Health and Care Excellence. Antenatal care. Aug 2021 [internet publication].Texto completo
6. da Fonseca TM, Cesar JA, Mendoza-Sassi RA, et al. Pathological vaginal discharge among pregnant women: pattern of occurrence and association in a population-based survey. Obstet Gynecol Int. 2013;2013:590416.Texto completo Resumo
7. Prasad D, Parween S, Kumari K, et al. Prevalence, etiology, and associated symptoms of vaginal discharge during pregnancy in women seen in a tertiary care hospital in Bihar. Cureus. 2021 Jan 14;13(1):e12700.Texto completo Resumo
8. Cesar JA, Mendoza-Sassi RA, González-Chica DA, et al. Prevalence of self-reported vaginal discharge and associated factors in pregnant women [in Portuguese]. Cad Saude Publica. 2009 Dec;25(12):2705-14.Texto completo Resumo
9. Centers for Disease Control and Prevention. Sexually transmitted infections treatment guidelines, 2021. Jul 2021 [internet publication].Texto completo
10. Mitchell H. Vaginal discharge-causes, diagnosis, and treatment. BMJ. 2004 May 29;328(7451):1306-8.Texto completo Resumo
11. Sobel JD. Vulvovaginitis in healthy women. Compr Ther. 1999 Jun-Jul;25(6-7):335-46. Resumo
12. Sobel JD. Pathogenesis of recurrent vulvovaginal candidiasis. Curr Inf Dis Rep. 2002 Dec;4(6):514-9. Resumo
13. Goje O, Munoz JL. Vulvovaginitis: find the cause to treat it. Cleve Clin J Med. 2017 Mar;84(3):215-24.Texto completo Resumo
14. Angelou K, Grigoriadis T, Diakosavvas M, et al. The genitourinary syndrome of menopause: an overview of the recent data. Cureus. 2020 Apr 8;12(4):e7586.Texto completo Resumo
15. Koumans EH, Sternberg M, Bruce C, et al. The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive health. Sex Transm Dis. 2007 Nov;34(11):864-9. Resumo
16. Hoffmann JN, You HM, Hedberg EC, et al. Prevalence of bacterial vaginosis and Candida among postmenopausal women in the United States. J Gerontol B Psychol Sci Soc Sci. 2014 Nov;69 Suppl 2(suppl 2):S205-14.Texto completo Resumo
17. Peebles K, Velloza J, Balkus JE, et al. High global burden and costs of bacterial vaginosis: a systematic review and meta-analysis. Sex Transm Dis. 2019 May;46(5):304-11.Texto completo Resumo
18. Fredricks DN, Fiedler TL, Marrazzo JM. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med. 2005 Nov 3;353(18):1899-911.Texto completo Resumo
19. Hill GB. The microbiology of bacterial vaginosis. Am J Obstet Gynecol. 1993 Aug;169(2 Pt 2):450-4. Resumo
20. Hay P. Recurrent bacterial vaginosis. Curr Infect Dis Rep. 2000 Dec;2(6):506-12. Resumo
21. Sobel JD, Kaur N, Woznicki NA, et al. Prognostic indicators of recurrence of bacterial vaginosis. J Clin Microbiol. 2019 May;57(5):e00227-19.Texto completo Resumo
22. Schwebke J, Desmond R. A randomized trial of metronidazole in asymptomatic bacterial vaginosis to prevent the acquisition of sexually transmitted diseases. Am J Obstet Gynecol. 2007 Jun;196(6):517;e1-6.Texto completo Resumo
23. Peipert J, Montagno AB, Cooper AS, et al. Bacterial vaginosis as a risk factor for upper genital tract infection. Am J Obstet Gynecol. 1997 Nov;177(5):1184-7. Resumo
24. British Association for Sexual Health and HIV. UK National guideline for the management of bacterial vaginosis. 2012 [internet publication].Texto completo
25. Taha TE, Hoover DR, Dallabetta GA, et al. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS. 1998 Sep 10;12(13):1699-706. Resumo
26. Sena AC, Miller WC, Hobbs MM, et al. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention. Clin Infect Dis. 2007 Jan 1;44(1):13-22. Resumo
27. Vutyavanich T, Pongsuthirak P, Vannareumol P, et al. A randomized double-blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstet Gynecol. 1993 Oct;82(4 Pt 1):550-4. Resumo
28. Leitich H, Bodner-Adler B, Brunbauer M, et al. Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis. Am J Obstet Gynecol. 2003 Jul;189(1):139-47. Resumo
29. Hillier SL, Nugent RP, Eschenbach DA, et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med. 1995 Dec 28;333(26):1737-42.Texto completo Resumo
30. Brocklehurst P, Gordon A, Heatley E, et al. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev. 2013 Jan 31;(1):CD000262.Texto completo Resumo
31. Klebanoff MA, Schuit E, Lamont RF, et al. Antibiotic treatment of bacterial vaginosis to prevent preterm delivery: systematic review and individual participant data meta-analysis. Paediatr Perinat Epidemiol. 2023 Mar;37(3):239-51.Texto completo Resumo
32. Kahwati LC, Clark R, Berkman N, et al. Screening for bacterial vaginosis in pregnant adolescents and women to prevent preterm delivery: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2020 Apr 7;323(13):1293-1309.Texto completo Resumo
33. Kahwati LC, Clark R, Berkman ND, et al. Screening for bacterial vaginosis in pregnant adolescents and women to prevent preterm delivery [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2020 Apr. Report No.: 19-05259-EF-1.Texto completo Resumo
34. Anderson MR, Klink K, Cohrssen A. Evaluation of vaginal complaints. JAMA. 2004 Mar 17;291(11):1368-79. Resumo
35. Kreisel KM, Spicknall IH, Gargano JW, et al. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2018. Sex Transm Dis. 2021 Apr 1;48(4):208-14.Texto completo Resumo
36. Rowley J, Vander Hoorn S, Korenromp E, et al. Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ. 2019 Aug 1;97(8):548-62P.Texto completo Resumo
37. Centers for Disease Control and Prevention. Sexually transmitted infections (STIs) are very common and costly to the nation’s health and economy. Jan 2021 [internet publication].Texto completo
38. Krieger JN. Urologic aspects of trichomoniasis. Invest Urol. 1981 May;18(8):411-7. Resumo
39. Sherrard J, Pitt R, Hobbs KR, et al. British Association for Sexual Health and HIV (BASHH) United Kingdom national guideline on the management of Trichomonas vaginalis 2021. Int J STD AIDS. 2022 Jul;33(8):740-50. Resumo
40. Sherrard J, Wilson J, Donders G, et al. 2018 European (IUSTI/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge. Int J STD AIDS. 2018 Nov;29(13):1258-72. Resumo
41. Røttingen JA, Cameron DW, Garnett GP. A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known? Sex Transm Dis. 2001 Oct;28(10):579-97.Texto completo Resumo
42. Wang CC, McClelland RS, Reilly M, et al. The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1. J Infect Dis. 2001 Apr 1;183(7):1017-22.Texto completo Resumo
43. Kissinger P, Amedee A, Clark RA, et al. Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding. Sex Transm Dis. 2009 Jan;36(1):11-6.Texto completo Resumo
44. Sobel JD. Vaginal infections in adult women. Med Clin North Am. 1990 Nov;74(6):1573-602. Resumo
45. Yano J, Sobel JD, Nyirjesy P, et al. Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes. BMC Womens Health. 2019 Mar 29;19(1):48.Texto completo Resumo
46. Ferris DG, Nyirjesy P, Sobel JD, et al. Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis. Obstet Gynecol. 2002 Mar;99(3):419-25. Resumo
47. De Leon EM, Jacober SJ, Sobel JD, et al. Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes. BMC Infect Dis. 2002 Jan 30;2:1. Resumo
48. National Institute for Health and Care Excellence. Candida - female genital: what are the risk factors? July 2022 [internet publication].Texto completo
49. Eckert LO, Hawes SE, Stevens CE, et al. Vulvovaginal candidiasis: clinical manifestations, risk factors, management algorithm. Obstet Gynecol. 1998 Nov;92(5):757-65. Resumo
50. Jensen JS, Cusini M, Gomberg M, et al. 2021 European guideline on the management of Mycoplasma genitalium infections. J Eur Acad Dermatol Venereol. 2022 May;36(5):641-50. Resumo
51. Sobel JD. Vaginitis. N Engl J Med. 1997 Dec 25;337(26):1896-903. Resumo
52. Verstraelen H, Verhelst R, Vaneechoutte M, et al. Group A streptococcal vaginitis: an unrecognized cause of vaginal symptoms in adult women. Arch Gynecol Obstet. 2011 Jul;284(1):95-8. Resumo
53. Yirenya-Tawiah D, Amoah C, Apea-Kubi KA, et al. A survey of female genital schistosomiasis of the lower reproductive tract in the Volta basin of Ghana. Ghana Med J. 2011 Mar;45(1):16-21.Texto completo Resumo
54. Foda AA, El-Malky MM. Prevalence of genital tract infection with Entamoeba gingivalis among copper T 380A intrauterine device users in Egypt. Contraception. 2012 Jan;85(1):108-12. Resumo
55. Rodrigues AC, Teixeira R, Teixeira T, et al. Impact of pelvic radiotherapy on female sexuality. Arch Gynecol Obstet. 2012 Feb;285(2):505-14. Resumo
56. Baessler K, Hewson AD, Tunn R, et al. Severe mesh complications following intravaginal slingplasty. Obstet Gynecol. 2005 Oct;106(4):713-6. Resumo
57. US Food and Drug Administration. Urogynecologic surgical mesh implants. Aug 2021 [internet publication].Texto completo
58. US Food and Drug Administration. FDA's activities: urogynecologic surgical mesh. Oct 2022 [internet publication].Texto completo
59. NHS Improvement and NHS England. Vaginal mesh: high vigilance restriction period. Provider Bulletin. 11 Jul 2018 [internet publication].Texto completo
60. NHS Improvement and NHS England. Extension of pause on the use of vaginal mesh. 29 Mar 2019 [internet publication].Texto completo
61. Medicines and Healthcare products Regulatory Agency. Pause on the use of vaginally inserted surgical mesh for stress urinary incontinence. Jul 2018 [internet publication].Texto completo
62. NHS Resolution. Vaginal mesh: what is a vaginal mesh implant? Oct 2022 [internet publication].Texto completo
63. Sanfilippo JS, Wakim NG. Bleeding and vulvovaginitis in the pediatric age group. Clin Obstet Gynecol. 1987 Sep;30(3):653-61. Resumo
64. McGreal S, Wood P. Recurrent vaginal discharge in children. J Pediatr Adolesc Gynecol. 2013 Aug;26(4):205-8. Resumo
65. Jaquiery A, Stylianopoulos A, Hogg G, et al. Vulvovaginitis: clinical features, aetiology, and microbiology of the genital tract. Arch Dis Child. 1999 Jul;81(1):64-7.Texto completo Resumo
66. Striegel AM, Myers JB, Sorensen MD, et al. Vaginal discharge and bleeding in girls younger than 6 years. J Urol. 2006 Dec;176(6 Pt 1):2632-5. Resumo
67. Simon DA, Berry S, Brannian J, et al. Recurrent, purulent vaginal discharge associated with longstanding presence of a foreign body and vaginal stenosis. J Pediatr Adolesc Gynecol. 2003 Dec;16(6):361-3. Resumo
68. Merkley K. Vulvovaginitis and vaginal discharge in the pediatric patient. J Emerg Nurs. 2005 Aug;31(4):400-2. Resumo
69. Singh RH, Zenilman JM, Brown KM, et al. The role of physical examination in diagnosing common causes of vaginitis: a prospective study. Sex Transm Infect. 2013 May;89(3):185-90. Resumo
70. Chinnock B, Yore M, Mason J, et al. Self-obtained vaginal swabs are not inferior to provider-performed endocervical sampling for emergency department diagnosis of Neisseria gonorrhoeae and Chlamydia trachomatis. Acad Emerg Med. 2021 Jun;28(6):612-20.Texto completo Resumo
71. Barnes P, Vieira R, Harwood J, et al. Self-taken vaginal swabs versus clinician-taken for detection of candida and bacterial vaginosis: a case-control study in primary care. Br J Gen Pract. 2017 Dec;67(665):e824-9.Texto completo Resumo
72. Strauss RA, Eucker B, Savitz DA, et al. Diagnosis of bacterial vaginosis from self-obtained vaginal swabs. Infect Dis Obstet Gynecol. 2005 Mar;13(1):31-5.Texto completo Resumo
73. Smith K, Harrington K, Wingood G, et al. Self-obtained vaginal swabs for diagnosis of treatable sexually transmitted diseases in adolescent girls. Arch Pediatr Adolesc Med. 2001 Jun;155(6):676-9.Texto completo Resumo
74. Van Der Pol B, Williams JA, Taylor SN, et al. Detection of Trichomonas vaginalis DNA by use of self-obtained vaginal swabs with the BD ProbeTec Qx assay on the BD Viper system. J Clin Microbiol. 2014 Mar;52(3):885-9.Texto completo Resumo
75. Miller JM, Binnicker MJ, Campbell S, et al. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis. 2018 Aug 31;67(6):e1-94.Texto completo Resumo
76. Coleman JS, Gaydos CA. Molecular diagnosis of bacterial vaginosis: an update. J Clin Microbiol. 2018 Sep;56(9):e00342-18.Texto completo Resumo
77. Soni S, Horner P, Rayment M, et al. British Association for Sexual Health and HIV national guideline for the management of infection with Mycoplasma genitalium (2018). Int J STD AIDS. 2019 Sep;30(10):938-50.Texto completo Resumo
78. Phillips NA, Bachmann GA. Genitourinary syndrome of menopause: common problem, effective treatments. Cleve Clin J Med. 2018 May;85(5):390-8.Texto completo Resumo
79. Kleppa E, Holmen SD, Lillebø K, et al. Re: Al-Baghdadi O, Samarasinghe A, Wissa I. 2014. Cervical schistosomiasis. Journal of Obstetrics and Gynaecology 34:206. J Obstet Gynaecol. 2014;34(8):755-6. Resumo
80. Stott D, Zakaria M. The transcervical expulsion of a large fibroid. BMJ Case Reports. BMJ Case Rep. 2012 Sep 24;2012:bcr0120125523.Texto completo Resumo
81. de la Poza G, López-Sanroman A, Taxonera C, et al. Genital fistulas in female Crohn's disease patients: clinical characteristics and response to therapy. J Crohns Colitis. 2012 Apr;6(3):276-80. Resumo
82. Bates S. Vaginal discharge. Current Obstetrics & Gynaecology. 2003 Aug;13(4):218-23.
83. Ou YC, Huang HY, Huang CC, et al. Primary fallopian tube carcinoma: clinicopathological analysis of 12 cases. Taiwan J Obstet Gynecol. 2011 Jun;50(2):141-4. Resumo
84. Cao XX, Li J, Zhang W, et al. Patients with primary diffuse large B-cell lymphoma of female genital tract have high risk of central nervous system relapse. Ann Hematol. 2014 Jun;93(6):1001-5. Resumo
85. Bull L, Knowles A, Ogden S, et al. Primary cervical lymphoma: a rare presentation to a genitourinary medicine clinic. Int J STD AIDS. 2013 Jul;24(7):587-9. Resumo
86. Nelson TM, Borgogna JC, Michalek RD, et al. Cigarette smoking is associated with an altered vaginal tract metabolomic profile. Sci Rep. 2018 Jan 16;8(1):852.Texto completo Resumo
87. Mittal V, Jain A, Pradeep Y. Development of modified diagnostic criteria for bacterial vaginosis at peripheral health centres in developing countries. J Infect Dev Ctries. 2012 May 14;6(5):373-7. Resumo
88. Amsel R, Totten PA, Spiegel CA, et al. Nonspecific vaginitis: diagnostic criteria and microbial and epidemiologic associations. Am J Med. 1983 Jan;74(1):14-22. Resumo
89. Simoes JA, Discacciati MG, Brolazo EM, et al. Clinical diagnosis of bacterial vaginosis. Int J Gynaecol Obstet. 2006 Jul;94(1):28-32. Resumo
90. Gaydos CA, Hsieh YH, Barnes M, et al. Trichomonas vaginalis infection in women who submit self-obtained vaginal samples after internet recruitment. Sex Transm Dis. 2011 Sep;38(9):828-32. Resumo
91. Petrin D, Delgaty K, Bhatt R, et al. Clinical and microbiological aspects of Trichomonas vaginalis. Clin Microbiol Rev. 1998 Apr;11(2):300-17.Texto completo Resumo
92. Centers for Disease Control and Prevention. Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae - 2014. MMWR Recomm Rep. 2014;63(RR-02):1-19.Texto completo Resumo
93. Geisler WM, Chow JM, Schachter J, et al. Pelvic examination findings and Chlamydia trachomatis infection in asymptomatic young women screened with a nucleic acid amplification test. Sex Transm Dis. 2007 Jun;34(6):335-8. Resumo
94. Stenchever MA, Droegemueller W, Herbst AL, et al. Comprehensive gynecology. 4th ed. St. Louis, Missouri: Mosby; 2006; 655-6.
95. Centers for Disease Control and Prevention. Genital herpes. Sexually transmitted infections treatment guidelines, 2021. Sep 2022 [internet publication].Texto completo
96. Pretorius R, Semrad N, Watring W, et al. Presentation of cervical cancer. Gynecol Oncol. 1991 Jul;42(1):48-53. Resumo
O uso deste conteúdo está sujeito ao nosso aviso legal